Korea's Medical Tourism Just Hit a Record 2.01 Million Foreign Patients — and Most Aren't There for Plastic Surgery

If you've spent any time in K-beauty spaces online, you've probably seen the claim that "everyone is flying to Korea for plastic surgery." The 2025 numbers tell a more specific — and more useful — story. Korea's Ministry of Health and Welfare confirmed that 2.01 million foreign patients sought care in the country last year, the first time the figure has crossed 2 million since the government started tracking it in 2009. But when you actually break down what those 2 million people were there for, dermatology outnumbers plastic surgery by roughly six to one. This isn't a story about a nation of foreigners getting nose jobs; it's a story about Korea becoming the place the world goes for skin. Here's what the government's own data, industry association figures, and Korea Times' recent reporting actually show — including a discrepancy between two credible sources that's worth flagging rather than glossing over.

Quick Facts — Read This First

Bottom line	Korea treated 2.01 million foreign patients in 2025, a record and the first time the annual total has topped 2 million since data collection began in 2009
Growth	Up 71.9% from 1.17 million in 2024 — the third straight year of near-doubling growth (610,000 in 2023 → 1.17 million in 2024 → 2.01 million in 2025)
Economic impact	22.8 trillion won (about $14.6 billion) in total economic ripple effect, per Korea Institute for Industrial Economics & Trade (KIET) estimates cited by The Korea Times
What patients get treated for	Dermatology 62.9% (1.313 million patients) + plastic surgery 11.2% (233,000 patients), per Ministry of Health and Welfare — see the note below on why Korea Times reported a different combined figure
Where they go	87.2% of patients were treated inside Seoul city limits; that climbs to roughly 90% across the wider Seoul metro area
Top source country	China, 30.8% of all patients — the first year China has outranked Japan as Korea's top medical tourism source market

Aerial night view of Seoul's skyline with Lotte World Tower lit up, showing the dense high-rise concentration of the city where most foreign medical tourists to Korea are treated — Photo via Unsplash

The Record Number, and Why It's Not Really About Surgery

Korea's Ministry of Health and Welfare's 2025 tally puts foreign patients at 2.01 million, with a broader count of 2.72 million total patient visits once repeat visits by the same person are included. That's a 71.9% jump from 2024's 1.17 million, which itself was nearly double the 610,000 patients Korea saw in 2023. Three years running, the country has essentially doubled its foreign patient volume — a growth curve that stands out even among fast-growing medical tourism hubs in Asia. Patients arrived from 201 different countries or territories, and for the first time on record, China edged out Japan as the single largest source market, accounting for 30.8% of all foreign patients. Chinese and Taiwanese patient numbers more than doubled year-over-year, while American patient visits rose 70.4% and Canadian visits climbed 59.1%.

What most Western coverage of Korea's beauty industry misses is what those patients were actually there for. According to the Ministry's own specialty breakdown, dermatology accounted for 62.9% of all foreign patients — 1.313 million people getting lasers, injectables, skin boosters, and other non-surgical treatments — while plastic surgery accounted for 11.2%, or 233,000 patients. Internal medicine (9.2%, 192,000 patients) and health checkup centers (3.1%, 65,000 patients) rounded out the next-largest categories. In other words, the overwhelming majority of Korea's "medical tourism boom" is a skincare and dermatology story, not a surgery story — which lines up with how K-beauty content actually frames Korea abroad: as an established global leader in dermatology and skincare treatments, not primarily a surgery destination.

Korea Medical Tourism by the Numbers (2025)

Individual figures on Korea's medical tourism boom are scattered across government press releases, industry association statements, and separate news cycles. Pulled into one place, the full picture — and the one real discrepancy in the reporting — looks like this:

Metric	Figure	Source
Foreign patients, 2025	2.01 million (record; first time over 2M since tracking began in 2009)	Ministry of Health and Welfare
Year-over-year growth	+71.9% (from 1.17 million in 2024)	Ministry of Health and Welfare
Total economic ripple effect	22.8 trillion won (~$14.6B)	KIET, via The Korea Times
Direct patient/companion spending	12.5 trillion won total — only 3.3 trillion won of that was actual medical fees; the rest went to hotels, food, shopping, and transport	Ministry of Health and Welfare
Dermatology patients	62.9% (1.313 million)	Ministry of Health and Welfare / KHIDI (Korea Health Industry Development Institute)
Plastic surgery patients	11.2% (233,000)	Ministry of Health and Welfare / KHIDI (Korea Health Industry Development Institute)
Combined dermatology + plastic surgery	74.1% by the Ministry's own math — but The Korea Times' July 2 feature separately cited "68%." Neither outlet has reconciled the 6-point gap.	Ministry of Health and Welfare vs. The Korea Times
Seoul concentration	87.2% treated within Seoul city; ~90% across the wider Seoul metro area	Korea Herald / The Korea Times
Top source country	China, 30.8% of patients (first year overtaking Japan)	Ministry of Health and Welfare

On that discrepancy: the Ministry's own specialty-by-specialty breakdown — 62.9% dermatology plus 11.2% plastic surgery — adds up to 74.1% combined, which is the more granular, directly sourced figure and the one we'd recommend citing. The Korea Times' July 2, 2026 feature on Korea's medical tourism boom separately reported the combined share as "68%," without publishing its own specialty-by-specialty math. It's possible that figure reflects a slightly different data cut (a different time window, or a narrower definition of "cosmetic" procedures within dermatology), but neither the Ministry nor Korea Times has published a reconciliation. Rather than pick whichever number sounds cleaner, we're flagging both here — 74.1% is the figure that traces directly back to the primary government breakdown, while 68% is the rounder aggregate that's circulating in press coverage.

Where the Money Actually Goes

The 22.8 trillion won figure gets the headlines, but it's worth understanding what it actually measures. That number, estimated by the Korea Institute for Industrial Economics & Trade, is a broad economic ripple effect — it accounts for indirect activity across supply chains, not just what patients themselves spent. The direct spending figure, tracked separately by the Ministry, was 12.5 trillion won from patients and the people who traveled with them. Of that, only 3.3 trillion won — about a quarter — went to actual medical treatment. The other roughly 9.2 trillion won went to hotels, restaurants, shopping, transportation, and everything else that comes with a trip. That's the clearest evidence yet that medical tourism functions as a broader tourism engine for Korea, not just a healthcare export: a patient who comes for a skin treatment is also, functionally, a multi-day tourist with a hospital appointment on the itinerary.

Kim Jin-kuk, president of the Korea Medical Tourism Promotion Association (KMTPA), put the labor-market effect in blunt terms to The Korea Times: "Attracting one medical tourist means seven others work with them, including interpreters, nurses, travel agents and hotel staff." That framing — one patient supporting roughly seven jobs across interpretation, care, travel, and hospitality — is a large part of why the Korean government has kept investing in the sector.

The Seoul Problem

The other structural theme running through Korea's 2025 numbers is geographic concentration. Seoul alone treated 87.2% of all foreign patients in the country, and 62.5% of the clinics and hospitals registered to treat international patients are located in the capital. Widen the lens to the greater Seoul metropolitan area — Seoul plus the surrounding Incheon and Gyeonggi region — and that share climbs to roughly 90%, according to The Korea Times. Within Seoul, patient traffic skews heavily toward Gangnam and Seocho, the two districts most associated with Korea's dermatology and plastic surgery clinics, both online and in K-drama and variety-show references. That concentration is efficient in the short term — it clusters interpreters, specialists, and international patient coordinators in one walkable area — but Korean health officials and industry groups have flagged it as a long-term risk: almost none of this economic activity, or the jobs tied to it, reaches the rest of the country. If you're curious about the cultural backdrop that made Gangnam synonymous with aesthetic treatment in the first place, our deep dive into why plastic surgery became so normalized in Korea covers that from the domestic, cultural angle rather than the foreign-patient statistics angle this piece focuses on.

What's Driving the Boom — and One Thing That Just Changed

Three factors show up consistently across the reporting on why 2025 was such an outlier year. First, Korea extended visa-free entry to Chinese group tourists starting in late 2024, which coincided with Chinese patient visits surging 137.5% in 2025; industry observers widely cite the visa change as a leading driver behind China becoming Korea's top source market for the first time. Second, a decade-long 10% VAT refund on cosmetic and plastic surgery procedures for foreign patients made aesthetic treatments meaningfully cheaper for international visitors; Chinese patients alone were receiving an average of 293,000 won back per person, more than any other nationality. Third, the broader spread of Hallyu — K-pop, K-dramas, and K-beauty content — kept building global awareness of Korean dermatology and skincare as a category worth traveling for, the same cultural momentum covered in our K-Beauty Goes Global roundup. That second driver, though, won't be part of the 2026 numbers. Korea's government confirmed that the VAT refund scheme for foreign cosmetic surgery patients ended on December 31, 2025 — right as the record 2025 figures were being finalized. Industry observers quoted in Korean and international trade press have openly questioned whether removing that price incentive will push some cost-sensitive patients toward competing hubs like Thailand or Singapore. It's also part of why The Korea Times framed its July 2026 feature on these record numbers around "Korea's push for sustainability" — the 2025 peak may turn out to be as much a story about what's ending as what's still growing. A softer won has helped offset some of that on the travel-cost side; see our breakdown of why 2026 has been such a cheap year to visit Korea for the exchange-rate context that applies to medical travelers just as much as regular tourists.

What This Means If You're Actually Considering It

For the segment of K-beauty fans who follow this space because they're genuinely weighing a trip to Korea for skin treatment rather than surgery, the 2025 data is reassuring in one specific way: you would be firmly in the statistical majority, not an outlier. Roughly two-thirds of foreign patients in Korea last year were there for dermatology, not plastic surgery, and Seoul's Gangnam and Seocho districts have built enough international-patient infrastructure — interpreters, dedicated international clinics, coordinated travel packages — that non-surgical visits are a well-worn path, not a niche one. That said, the concentration numbers also mean pricing and appointment availability in Gangnam specifically can fluctuate with demand, and the end of the VAT refund removes a cost cushion that applied mainly to surgical and some injectable procedures, not routine dermatology visits. Anyone planning a trip around a specific treatment should confirm current after-tax pricing directly with a clinic rather than relying on figures from before January 2026. This article covers statistics and travel/cost context, not medical advice — treatment decisions should be made with a licensed provider.

FAQ

How many foreign patients visited Korea for medical treatment in 2025?
2.01 million, according to Korea's Ministry of Health and Welfare — a record and the first time the figure has exceeded 2 million since the government began tracking foreign patient data in 2009.

Do most foreign patients in Korea go there for plastic surgery?
No. Dermatology accounted for 62.9% of foreign patients (1.313 million people) versus 11.2% for plastic surgery (233,000 people), per the Ministry of Health and Welfare's own specialty breakdown. Non-surgical dermatology outnumbers plastic surgery by roughly six to one.

What is the economic impact of Korea's medical tourism industry?
The Korea Institute for Industrial Economics & Trade estimates a total ripple effect of 22.8 trillion won (about $14.6 billion). Separately, direct spending by patients and companions was measured at 12.5 trillion won, of which only 3.3 trillion won went to actual medical treatment — the rest was spent on hotels, food, shopping, and transportation.

Why do dermatology and plastic surgery figures differ between sources?
The Ministry of Health and Welfare's own breakdown (62.9% dermatology + 11.2% plastic surgery) adds up to 74.1% combined. The Korea Times separately reported a combined figure of 68% in its July 2026 coverage without publishing its own specialty math. The discrepancy hasn't been publicly reconciled by either source, so we've presented both here rather than choosing one.

Is Korea's medical tourism industry too concentrated in Seoul?
Yes, by a wide margin. Seoul city treated 87.2% of all foreign patients in 2025, and that share rises to roughly 90% across the broader Seoul metropolitan area. Korean health officials have flagged this concentration, centered on Gangnam and Seocho, as a structural risk for the industry's long-term balance.

Will Korea's medical tourism numbers keep growing in 2026?
That's uncertain. The 10% VAT refund for foreign cosmetic surgery patients, in place for roughly a decade, ended December 31, 2025 — right after the record 2025 figures were recorded. Industry observers have questioned whether removing that price incentive will slow growth or push cost-sensitive patients toward competing destinations like Thailand or Singapore.

Search This Blog

Hallyu101